PRMT1 was highly expressed in human BCL samples, roughly correlating with their proliferation: highest in Burkitt’s lymphoma (BL) and diffuse large BCL (DLBCL), and lowest in indolent chronic lymphocytic leukemia (Fig. 8 A). This evidence concerns the gene PRMT1 and B-cell chronic lymphocytic leukemia.